The replay is now available
Concomitant Aortic Stenosis & Mitral Regurgitation interventions - a case-based discussion
Moderator:
Dr Lionel Leroux, MD PhD
Chief of Interventional Cardiology,
CHU de Bordeaux
Speakers:
Ralph Stephan von Bardeleben
Head of the Heart Valve Center
Mainz University Medical Center
Prof. Rebecca Hahn
Director of interventional echocardiography, New York Presbyterian/Columbia University Medical Center, NYC
The replay is now available
Tricuspid Valve TriClip with Echo simulator
Discover how human grade simulators can assist in learning both advanced imaging with the new EPIQ CVxi 7.0 and device manipulations for tricuspid regurgitation procedures.
Performed by: Prof. Michel Zuber and Prof. Francesco Maisano from Zurich
The demands of transcatheter valvular and other structural heart procedures require a future-proof, fully integrated environment providing the right image and the right information at the right time.
The Azurion SHD suite was designed to adapt to your workflow needs, letting the system work seamlessly around you so that you may focus on your patient. In fact, the Philips Azurion platform boasts a reduction of procedure time by 17%1 (in an independently verified study for interventional radiology).
EchoNavigator reorients and combines ultrasound and X-ray information into a single augmented visualisation for guidance and device-tissue relationship
assessment.
EchoNavigator enables
• Importing ultrasound targets or critical structures as fluoroscopic annotations
• Live-on-live fusion of both modalities including 2D, 3D, and color flow
• ECG-gated dynamic segmentation of cardiac structures for view optimisation and orientation
• Flexible workspots at both tableside and on the EPIQ CVxi console
1. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.
2. Routine coronary interventions comprise of fluoroscopy and exposure usage.
3. (95% CI of 53%, 77% for all diagnostic and interventional coronary procedures). The results of the application of dose reduction techniques will vary depending on the clinical task, patient size, anatomical location and clinical practice. The interventional cardiologist assisted by a physicist as necessary has to determine the appropriate settings for each specific clinical task.
4. Results based on total dose area product from a single center prospective controlled randomized study (University Hospital Gent, Belgium) on 122 patients (42 for Allura Xper and 80 for AlluraClarity) undergoing coronary procedures. Of the 122 patients, 102 (83.6%) had a diagnostic procedure without intervention and 51 (41.8%) resulted in a diagnosis of no coronary disease. Patient radiation exposure was quantified using cumulative dose area product as collected from Radiation